List of insiders holdings for Quince Therapeutics Inc.:
- Shares directly owned by the insider.
- Shares indirectly owned by the insider.
- Total shares owned by the insider (sum of shares directly and indirectly owned).
- Total market value if available.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| # | Insider Holder Name | Report Date Time | Shares Owned Directly Indirectly | Total Shares Owned | Filing |
| 1 | LAMOND PIERRE Lamond Christine 10% Owner | 2019-09-30 08:43:53 | 2,886,530 0 | 2,886,530 | Form 13G |
| 2 | Thye Dirk CEO and CMO | 2025-06-23 08:43:12 | 1,145,829 0 | 1,145,829 | Form 4 |
| 3 | PFIZER INC Pfizer Strategic Investment Holdings LLC Pfizer Ventures (US) LLC 10% Owner | 2022-02-11 18:06:57 | 600,000 0 | 600,000 | Form 13G |
| 4 | Low Philip S Director | 2022-05-23 20:17:43 | 477,367 63,974 | 541,341 | Form 4 |
| 5 | Lynch Casey Chief Executive Officer | 2022-01-05 17:26:18 | 440,000 0 | 440,000 | Form 4 |
| 6 | Hannah Brendan CBO, COO & CCO | 2025-06-23 08:48:00 | 372,012 0 | 372,012 | Form 4 |
| 7 | Janhofer Guenter Chief Scientific Officer | 2023-10-24 19:42:07 | 300,000 0 | 300,000 | Form 4 |
| 8 | LOWE CHRISTOPHER P. Interim CEO, COO & CFO | 2022-03-04 17:55:40 | 265,000 0 | 265,000 | Form 4 |
| 9 | Smith Karen L. Chief Medical Officer | 2023-02-02 18:35:56 | 225,000 0 | 225,000 | Form 4 |
| 10 | Holsinger Leslie EVP, Preclinical Development | 2022-06-08 16:10:58 | 148,080 0 | 148,080 | Form 4 |
| 11 | Detke Michael J. Chief Medical Officer | 2022-03-04 17:39:59 | 140,000 0 | 140,000 | Form 4 |
| 12 | Ryan Charles S. President | 2025-06-23 08:46:04 | 137,557 0 | 137,557 | Form 4 |
| 13 | Dominy Stephen S. Chief Scientific Officer | 2022-01-05 16:53:10 | 125,000 0 | 125,000 | Form 4 |
| 14 | McDowell Caryn Gordon Chief Legal & Adm. Officer | 2022-06-08 16:09:19 | 122,500 0 | 122,500 | Form 4 |
| 15 | Gafric Kristen SVP, Legal & Administration | 2020-02-10 18:13:59 | 100,000 0 | 100,000 | Form 4 |
| 16 | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 2021-01-28 17:57:44 | 87,258 0 | 87,258 | Form 13G |
| 17 | Monohon Ted Chief Accounting Officer & VP | 2023-03-06 18:55:56 | 27,440 0 | 27,440 | Form 4 |
| 18 | Bray June Director | 2025-06-06 17:07:25 | 27,000 0 | 27,000 | Form 4 |
| 19 | Patni Rajiv Director | 2025-06-06 17:14:19 | 27,000 0 | 27,000 | Form 4 |
| 20 | McLoughlin Margaret Director | 2025-06-06 17:27:06 | 27,000 0 | 27,000 | Form 4 |
| 21 | Lamond David Director | 2025-06-06 17:33:18 | 27,000 0 | 27,000 | Form 4 |
| 22 | Senner Christopher J. Director | 2025-06-06 17:36:21 | 27,000 0 | 27,000 | Form 4 |
| 23 | Benatti Luca Director | 2025-06-06 17:38:57 | 27,000 0 | 27,000 | Form 4 |
| 24 | RYAN UNA S Director | 2025-06-06 17:52:41 | 27,000 0 | 27,000 | Form 4 |
| 25 | Sabbagh Marwan Director | 2022-03-16 18:33:46 | 22,058 0 | 22,058 | Form 4 |
| 26 | YOUNG KEVIN Director | 2020-06-09 20:22:01 | 11,029 0 | 11,029 | Form 4 |
| 27 | EPIQ Capital Group LLC Boeding Chad Former 10% Owner | 2021-02-01 16:25:27 | 0 0 | 0 | Form 5 |